Abstract
With the epidemiology now well described, stroke has been uncovered as a frequent cause of neurological disease in children. Arterial ischemic stroke (AIS) is the most common type, affecting both neonates and older children. The number of associated risk factors is large with current efforts directed toward understanding the mechanisms by which they translate into a stroke. Advanced neuroimaging modalities are improving diagnostic accuracy while affording unique avenues to explore the pathophysiology of stroke and the response of the developing brain to injury. While acute interventions for pediatric stroke are in their infancy, the first randomized controlled clinical trials for the initial management and secondary prevention of pediatric stroke are poised to begin. Outcomes from childhood stroke are well defined though the accurate predictors required to guide treatment and rehabilitation remain elusive. We review the essential background, recent advances, and current clinical research issues pertaining to AIS in children.
Keywords: Pediatric stroke, arterial ischemic stroke, cerebrovascular disease, child
Current Pediatric Reviews
Title: Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Volume: 2 Issue: 4
Author(s): Adam Kirton, Michael D. Hill and Gabrielle deVeber
Affiliation:
Keywords: Pediatric stroke, arterial ischemic stroke, cerebrovascular disease, child
Abstract: With the epidemiology now well described, stroke has been uncovered as a frequent cause of neurological disease in children. Arterial ischemic stroke (AIS) is the most common type, affecting both neonates and older children. The number of associated risk factors is large with current efforts directed toward understanding the mechanisms by which they translate into a stroke. Advanced neuroimaging modalities are improving diagnostic accuracy while affording unique avenues to explore the pathophysiology of stroke and the response of the developing brain to injury. While acute interventions for pediatric stroke are in their infancy, the first randomized controlled clinical trials for the initial management and secondary prevention of pediatric stroke are poised to begin. Outcomes from childhood stroke are well defined though the accurate predictors required to guide treatment and rehabilitation remain elusive. We review the essential background, recent advances, and current clinical research issues pertaining to AIS in children.
Export Options
About this article
Cite this article as:
Kirton Adam, Hill D. Michael and deVeber Gabrielle, Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues, Current Pediatric Reviews 2006; 2 (4) . https://dx.doi.org/10.2174/157339606778699635
DOI https://dx.doi.org/10.2174/157339606778699635 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Lipid Effects of Statins: Emerging New Indications
Current Vascular Pharmacology Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design Respiratory Syncytial Virus (RSV) Prevention and Treatment: Past, Present, and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Fibrate Treatment in Dyslipidemia: An Overview
Current Pharmaceutical Design Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Current Pharmaceutical Biotechnology Testosterone and Cardioprotection Against Myocardial Ischemia
Cardiovascular & Hematological Disorders-Drug Targets Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Meet the Editorial Board:
Current Drug Targets A Clinical Perspective of Soluble Epoxide Hydrolase Inhibitors in Metabolic and Related Cardiovascular Diseases
Current Molecular Pharmacology Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Current Diabetes Reviews Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications
Current Radiopharmaceuticals Withdrawal Notice: COVID-19: Outbreak to Global
Anti-Infective Agents Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Editorial:Circulating Biomarkers in Cardiovascular Diseases – A Field of Theoretical Research or Realistic Clinical Application?
Current Pharmaceutical Biotechnology Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Sirtuins and Resveratrol-Derived Compounds: A Model for Understanding the Beneficial Effects of the Mediterranean Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Effectiveness of Resveratrol Against Cardiovascular Disease
Mini-Reviews in Organic Chemistry Critical Overview of Applications of Genetic Testing in Sport Talent Identification
Recent Patents on DNA & Gene Sequences